National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from severe H5N1 avian influenza.
Daiichi Sankyo and MSD expand collaboration for ADCs
MK-6070 was acquired by MSD through its purchase of Harpoon Therapeutics. Credit: Merck & Co., Inc., Rahway, NJ USA, and its affiliates. Daiichi Sankyo and
August 7, 2024